Evidence map›Paper›PMID 40668097›Full record

ArticleThe Journal of infectious diseases2025

Characteristics of Human Metapneumovirus Infection Compared to Respiratory Syncytial Virus and Influenza Infections in Adults Hospitalized for Influenza-Like Illness in France, 2012-2022.

Paul Loubet, Salomé Guitton, Simon Rolland, Louise H Lefrancois, Liem Binh Luong Nguyen, Philippe Vanhems, Fabrice Laine, Florence Galtier, Xavier Duval, Bruno Lina and 9 more

Abstract readComparative Study
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Paul LoubetVirulence Bactérienne et Infections Chroniques, INSERM U1047, Univ Montpellier, Service des Maladies Infectieuses et Tropicales, CHU Nîmes, Nîmes.ORCID 0000-0002-1218-9432
Salomé GuittonInserm SC10-US19, Villejuif.
Simon RollandService des maladies infectieuses et tropicales, Centre Hospitalier Universitaire de Brest.ORCID 0000-0001-8485-7690
Louise H LefrancoisInserm, F-CRIN, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Paris.
Liem Binh Luong NguyenUniversité Paris Cité, Inserm, Centre d'Investigation Clinique Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris.ORCID 0000-0002-5235-0868
Philippe VanhemsService d'Hygiène, Epidémiologie et Prévention, Hospices Civils de Lyon.
Fabrice LaineCentre d'Investigations Cliniques, Inserm, Unité mixte de recherche, Centre d'Investigation Clinique 1414, Hôpital Pontchaillou, Rennes.
Florence GaltierInserm, Centre d'Investigation Clinique 1411, Centre Hospitalier Universitaire Montpellier, Hôpital Saint Eloi, Montpellier.ORCID 0000-0002-0720-6277
Xavier DuvalUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm 1137, Infection, Antimicrobials, Modelling, Evolution, Paris.
Bruno LinaLaboratoire de Virologie, Hospices Civils de Lyon, Institut des Agents Infectieux, Centre National de Référence des virus Respiratoires France Sud, Hôpital de la Croix-Rousse, Lyon.
Martine ValetteLaboratoire de Virologie, Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Rennes.
Giséle LagathuLaboratoire de Virologie, Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Rennes.
Vincent FoulongneService de Virologie, Centre Hospitalier Universitaire Montpellier, Hoôpital Saint Eloi, Montpellier.
Nadira Houhou-FidhouLaboratoire de Virologie, Hoôpital Bichat Claude Bernard, Paris.
Anne Sophie L'HonneurService de Virologie, Hoôpital Cochin, Paris.ORCID 0000-0002-9228-0649
Fabrice CarratSorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique Hôpitaux de Paris, Hôpital Saint Antoine, Paris.ORCID 0000-0002-8672-7918
Laurence MeyerInserm SC10-US19, Villejuif.
Christine DurierInserm SC10-US19, Villejuif.
Odile LaunayInserm, F-CRIN, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Paris.

Funding

ANRSI-REIVACMIE
6 · The paper itself

Abstract

backgroundWe aimed to compare the characteristics of human metapneumovirus (hMPV) infection with influenza A and B virus (FLUV) and respiratory syncytial virus (RSV) infections in adults hospitalized with influenza-like illness (ILI).

methodsWe conducted a post hoc analysis of adult patients hospitalized with community-acquired ILI who were enrolled in the FLUVAC study at 5 French referral hospitals from 2012 to 2022.

resultsAt least 1 respiratory virus was detected in 3620 of 6618 patients (55%), including FLUV (1524/3620 [42%]), RSV (248/3620 [7%]), and hMPV (162/3620 [5%]). hMPV+ patients, when compared to FLUV+ patients were more likely to develop at least 1 complication (60% [86/143] vs 50% [716/1435]; P = .02), especially acute heart failure, which occurred twice as often in hMPV+ during the hospital stay (22% [32/143] vs 11% [160/1434]; P < .001). The rates of respiratory (30% [43/143] vs 32% [70/216]; P = .73) or cardiac (22% [32/143] vs 15% [33/216]; P = .09) complications did not differ between hMPV+ and RSV+ patients. The in-hospital all-cause death rate was similar among all 3 populations (4% hMPV+, 4% FLUV+, and 5% RSV+).

conclusionsHospitalized hMPV infections affect older patients with multiple chronic conditions who face frequent cardiac and pulmonary complications during hospitalization more frequently than with influenza and similar to RSV.

Indexed as

Influenza, HumanMetapneumovirusParamyxoviridae InfectionsRespiratory Syncytial Virus InfectionsAdultAgedAged, 80 and overCommunity-Acquired InfectionsFemaleFranceHospitalizationHumansMaleMiddle AgedRespiratory Tract InfectionsYoung Adultadultshospitalizationhuman metapneumovirusinfluenzarespiratory syncytial virus

Identifiers

PMID40668097
PMCPMC12265065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.